Research Article - (2013) Volume 4, Issue 6
Attenuating Janus Kinases (JAK) by Tofacitinib Effectively Prevented Psoriasis Pathology in Various Mouse Skin Inflammation Models
- Hak-Ling Ma1, Katherine Masek-Hammerman2, Susan Fish1, Lee Napierata1, Eva Nagiec2, Martin Hegen1 and James D Clark1*
- 1Immunoscience Research Unit, Pfizer WR&D., Cambridge, MA, USA
- 2Drug Safety Research & Development, Pfizer WR&D., Cambridge, MA, USA
*Corresponding Author:
James D Clark,
Ph.D., Immunoscience Research Unit, Pfizer W R&D., 200 Cambridge Park Drive, Cambridge, MA 02140, USA, Tel: +1-617-665-5475, Fax: +1-617-665-5499
Email:
